Bioabsorbable Stents Are Advancing With Increasing Technological Development In The Field Of Interventional Cardiology
Bioabsorbable Stents are used for percutaneous coronary intervention (PCI) to restore the blood flow to the affected vessel. These devices are made of materials that are absorbed by the body and dissolve after a few days. They also serve as a delivery vehicle for medications.
Cardiovascular diseases are the leading cause of death worldwide. Hospitals are the key end users of bioabsorbable materials. Due to the increase in the number of cardiac procedures and the rising prevalence of coronary artery disease, hospitals are expected to lead the demand for bioabsorbable materials.
Bioabsorbable Stents, or BVS, are promising devices in the treatment of coronary artery disease. However, they have several disadvantages. Some experts say that BVS are only appropriate for a minority of patients. Other surgeons think that the technology is still in its early stages. It's unclear whether this technology is ready to enter clinical trials and become a standard part of the interventional cardiologist's toolbox. In the meantime, a variety of companies are developing bioabsorbable material for various purposes.
While the bioresorbable material itself is promising, a new technique needs to be developed to ensure that the device remains intact for long-term use. One method involves integrating an inductive stent antenna. Another method involves a wireless pressure sensor. Both of these technologies could potentially lead to the development of smart stents with embedded sensors that can detect in-stent restenosis, delay endothelialization, and integrate cardiovascular biology and engineering.
The Bioabsorbable Stents Market is expanding as a result of the rising frequency of cardiovascular illnesses worldwide.
These developments have the potential to revolutionize the field of interventional cardiology. Smart stents that incorporate wireless pressure and fringe-field-capacitive sensing are a new paradigm in patient health care. They can detect small vessel pulse variations and measure vessel diameter with respect to time.
A fully absorbable, flexible stent system based on a poly (D-lactide) wireless pressure sensor demonstrated a high degree of linearity in the pressure range of 0-120 mmHg. In December 2020, Dotter Inc. a leading bioabsorbable company in Korea started clinical trial for evaluating the effectiveness and safety of the drug-eluting bioabsorbable stent Dotter BRS of the company.

Comments
Post a Comment